z-logo
open-access-imgOpen Access
Heterozygous OPA1 mutations in Behr syndrome
Author(s) -
Cécilia Marelli,
Patrizia AmatiBonneau,
Pascal Reynier,
Valérie Layet,
Antoine Layet,
Giovanni Stévanin,
E. Brissaud,
Dominique Bonneau,
A. Dürr,
Alexis Brice
Publication year - 2010
Publication title -
brain
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.142
H-Index - 336
eISSN - 1460-2156
pISSN - 0006-8950
DOI - 10.1093/brain/awq306
Subject(s) - atrophy , ataxia , medicine , pathology , pediatrics , psychiatry
ARTICLESir, We read with interest the paper by Yu-Wai-Man et al. (2010) on patients with dominant optic atrophy-plus with OPA1 mutations, which follows on previous reports by the same group (Amati-Bonneau et al. , 2008; Hudson et al. , 2008), reporting the relatively high frequency (∼20%) and the large spectrum of extra-ocular neurological involvement in OPA1 disease.Here, we extend the clinical spectrum of OPA1 mutations to Behr syndrome, characterized by early-onset optic atrophy associated with pyramidal signs, ataxia and sometimes, posterior column sensory loss and mental retardation (Behr 1909; Thomas et al. , 1984). This clinical entity is probably a heterogeneous group of disorders, whose real causes are mostly unknown. In most cases, autosomal recessive inheritance has been suspected. A few patients with typical Behr syndrome and several with Costeff syndrome, a Behr syndrome-like disease associating optic atrophy with extrapyramidal signs, were shown to have type III 3-methylglutaconic aciduria (MGA type III), a recessive disease characterized …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom